Yang Huang
Stock Analyst at J.P. Morgan
(4.74)
# 637
Out of 4,423 analysts
118
Total ratings
62.2%
Success rate
31.7%
Average return
Main Sectors:
Stocks Rated by Yang Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Buy | $129.00 | $68.50 | +88.32% | 13 | Jun 9, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $111.00 → $113.00 | $76.15 | +48.39% | 18 | Apr 30, 2026 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Maintained: Buy | $138.00 → $150.00 | $128.70 | +16.55% | 11 | Mar 26, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $499.00 → $545.00 | $415.80 | +31.07% | 2 | Nov 24, 2025 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Maintained: Sell | $18.00 → $20.00 | $16.38 | +22.10% | 9 | Oct 30, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Maintained: Sell | $37.00 → $38.00 | $31.34 | +21.25% | 8 | Oct 29, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Initiated Coverage: Buy | $43.00 | $29.96 | +43.52% | 1 | Sep 25, 2025 | |
| HKG: 1276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Initiated Coverage: Hold | $78.00 | $54.65 | +42.73% | 1 | Sep 23, 2025 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $99.00 → $166.00 | $87.55 | +89.61% | 11 | Aug 27, 2025 | |
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $16.00 → $24.00 | $11.79 | +103.56% | 2 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36.00 → $37.00 | $30.82 | +20.05% | 10 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46.00 → $74.00 | $46.70 | +58.46% | 6 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52.00 → $93.00 | $32.70 | +184.40% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84.00 → $80.00 | $35.10 | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $186.00 → $183.60 | $163.70 | n/a | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.40 | $1.59 | n/a | 1 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $217 → $64 | $18.18 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4.80 → $3.00 | $1.98 | n/a | 3 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26.50 | $7.81 | n/a | 1 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14.00 | $6.89 | n/a | 4 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18.00 | $10.40 | n/a | 2 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $9.00 → $11.00 | $16.23 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 → $169 | $270.15 | n/a | 4 | Mar 26, 2020 |
RemeGen Co., Ltd.
Jun 9, 2026
Maintained: Buy
Price Target: $129.00
Current: $68.50
Upside: +88.32%
Innovent Biologics, Inc.
Apr 30, 2026
Maintained: Buy
Price Target: $111.00 → $113.00
Current: $76.15
Upside: +48.39%
WuXi AppTec Co., Ltd.
Mar 26, 2026
Maintained: Buy
Price Target: $138.00 → $150.00
Current: $128.70
Upside: +16.55%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 24, 2025
Maintained: Buy
Price Target: $499.00 → $545.00
Current: $415.80
Upside: +31.07%
Shanghai Junshi Biosciences Co., Ltd.
Oct 30, 2025
Maintained: Sell
Price Target: $18.00 → $20.00
Current: $16.38
Upside: +22.10%
Hangzhou Tigermed Consulting Co., Ltd
Oct 29, 2025
Maintained: Sell
Price Target: $37.00 → $38.00
Current: $31.34
Upside: +21.25%
Hansoh Pharmaceutical Group Company Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $43.00
Current: $29.96
Upside: +43.52%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Sep 23, 2025
Initiated Coverage: Hold
Price Target: $78.00
Current: $54.65
Upside: +42.73%
Akeso, Inc.
Aug 27, 2025
Maintained: Buy
Price Target: $99.00 → $166.00
Current: $87.55
Upside: +89.61%
Genscript Biotech Corporation
Aug 21, 2025
Maintained: Buy
Price Target: $16.00 → $24.00
Current: $11.79
Upside: +103.56%
Aug 21, 2025
Maintained: Buy
Price Target: $36.00 → $37.00
Current: $30.82
Upside: +20.05%
Aug 14, 2025
Maintained: Buy
Price Target: $46.00 → $74.00
Current: $46.70
Upside: +58.46%
Aug 7, 2025
Maintained: Buy
Price Target: $52.00 → $93.00
Current: $32.70
Upside: +184.40%
May 16, 2023
Maintained: Buy
Price Target: $84.00 → $80.00
Current: $35.10
Upside: n/a
Mar 7, 2023
Maintained: Buy
Price Target: $186.00 → $183.60
Current: $163.70
Upside: n/a
Feb 22, 2023
Upgraded: Buy
Price Target: $3.40
Current: $1.59
Upside: n/a
Nov 14, 2022
Maintained: Buy
Price Target: $217 → $64
Current: $18.18
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $4.80 → $3.00
Current: $1.98
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $26.50
Current: $7.81
Upside: n/a
Aug 31, 2021
Maintained: Buy
Price Target: $14.00
Current: $6.89
Upside: n/a
Aug 27, 2021
Maintained: Hold
Price Target: $18.00
Current: $10.40
Upside: n/a
Jun 29, 2021
Downgraded: Hold
Price Target: $9.00 → $11.00
Current: $16.23
Upside: n/a
Mar 26, 2020
Maintained: Buy
Price Target: $230 → $169
Current: $270.15
Upside: n/a